Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies

Myelodysplastic syndromes

Imetelstat improves patient-reported outcomes and quality of life in lower-risk myelodysplastic syndromes: results from the phase III IMerge study

Haematologica

Sekeres MA, Zeidan AM, Santini V, Komrokji RS, Fenaux P, Savona MR, Madanat YF, Valcárcel D, Regnault A, Creel K, Sun L, Wan Y, Navada S, Berry T, Feller F, Platzbecker U, Díez-Campelo M, Oliva EN

doi: 10.3324/haematol.2025.288956

Myelodysplastic syndromes

Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients

Br J Haematol

Bouchla A, Papageorgiou SG, Kotsianidis I, Diamantopoulos P, Gavriilaki E, Bouronikou E, Symeonidis A, Zikos P, Cetiner M, Vlachaki E, Kostourou A, Galanopoulos A, Hatzimichael E, Vervesou EC, Bozdağ SC, Viniou NA, Christoulas D, Dellatola M, Papaioannou M, Papoutselis M, Vlachopoulou D, Syrigou A, Mainou M, Chatzileontiadou S, Pappa V

doi: 10.1111/bjh.20102

Leukemia

Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients

Blood Cancer J

Alsugair A, Gauto Mariotti E, Alhousani MM, Fathima S, Yousuf M, Bolarinwa A, Foran J, Mangaonkar AA, Litzow M, Murthy H, Sproat L, Palmer J, Matin A, Ayala E, Slack J, Porrata L, Iqbal M, Khera N, Punwani N, Kenderian S, Chhabra S, Hogan WJ, Shah MV, Alkhateeb HB, Gangat N, Patnaik M, Tefferi A

doi: 10.1038/s41408-025-01359-w

Myelodysplastic syndromes

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial

Adv Ther

Garcia-Manero G, Santini V, Zeidan AM, Komrokji RS, Pozharskaya V, Rose S, Keeperman K, Lai Y, Kalsekar S, Aggarwal B, Miteva D, Valcárcel D, Fenaux P, Shortt J, Della Porta MG, Platzbecker U

doi: 10.1007/s12325-025-03208-5

Leukemia

Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Am J Hematol

Ru Y, Chen J, Ferhat AT, Labussière-Wallet H, Gedde-Dahl T, Kröger N, Socié G, Yakoub-Agha I, Eder M, Mielke S, Wu D, Mohty M, Ciceri F, Gorin NC

doi: 10.1002/ajh.70069

EHA 2025

Lymphoma

ECHO: Frontline acalabrutinib triplet regimen improves clinical outcomes in patients with high-risk MCL

EHA 2025

Multiple Myeloma (MM)

GMMG-CONCEPT: Isatuximab plus KRd leads to high and sustained MRD negativity in transplant-eligible patients with high-risk NDMM

Leukemia

Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia

Leuk Lymphoma

McCormick B, Findley A, Diebold K, Bourne G, Hardee M, Foran J, Kharfan-Dabaja M, Murthy H, Iqbal M, Gangat N, Sproat L, Palmer J, Hogan WJ, Begna K, Litzow M, Tefferi A, Patnaik M, Bhatia R, Jamy O, Badar T

doi: 10.1080/10428194.2025.2564766

Myelodysplastic syndromes

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms

Br J Haematol

Maeda T, Matsuda A, Kanda J, Kawabata H, Ishikawa T, Tohyama K, Kitanaka A, Araseki K, Shimbo K, Hata T, Suzuki T, Kayano H, Usuki K, Shindo-Ueda M, Arima N, Nohgawa M, Ohta A, Chiba S, Miyazaki Y, Nakao S, Ozawa K, Arai S, Kurokawa M, Takaori-Kondo A, Mitani K, Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes

doi: 10.1111/bjh.20097

Related content

Imetelstat improves patient-reported outcomes and quality of life in lower-risk myelodysplastic syndromes: results from the phase III IMerge study

Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients

Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial

ECHO: Frontline acalabrutinib triplet regimen improves clinical outcomes in patients with high-risk MCL

GMMG-CONCEPT: Isatuximab plus KRd leads to high and sustained MRD negativity in transplant-eligible patients with high-risk NDMM

Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms